Curcumin as a Possible Lead Compound against Hormone-Independent, Multidrug-Resistant Breast Cancer-Reference-Cited by-同舟云学术

Curcumin as a Possible Lead Compound against Hormone-Independent, Multidrug-Resistant Breast Cancer

Published:2009-02 Issue:1 Volume:1155 Page:278-283
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Labbozzetta Manuela,Notarbartolo Monica,Poma Paola,Maurici Annamaria,Inguglia Luigi,Marchetti Paolo,Rizzi Michele,Baruchello Riccardo,Simoni Daniele,D'Alessandro Natale

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2009.03699.x/fullpdf

Reference22 articles.

1. Curcumin and cancer: An “old-age” disease with an “age-old” solution;Anand;Cancer Lett.,2008

2. Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol;Manson;Eur. J. Cancer,2005

3. Curcumin as a chemosensitizer;Limtrakul;Adv. Exp. Med. Biol.,2007

4. Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells;Simoni;Bioorg. Med. Chem. Lett.,2008

5. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells;Notarbartolo;Cancer Lett.,2005

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arachidonic acid in aging: New roles for old players;Journal of Advanced Research;2024-05

2. Mechanism insights of curcumin and its analogues in cancer: An update;Phytotherapy Research;2023-08-30

3. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward;Plants;2023-06-16

4. Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer;The American Journal of Chinese Medicine;2023-01

5. Phyto-nanotechnology: Enhancing Plant Based Chemical Constituent Mediated Anticancer Therapies;Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer;2023-01